techJuly 27, 2026·MIT Tech Review
Closing the data loop in AI-driven drug discovery
Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug
Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and costs…
Key Takeaways
- •Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage
- •This story was reported by MIT Tech Review, covering developments in the tech space.
- •AI advancements continue to reshape industries — read the full article on MIT Tech Review for complete coverage.
📖 Continue reading the full article:
Read Full Article on MIT Tech Review →
